Is there a role for combined anti-PD-1/CTLA-4 checkpoint blockade in the management of advanced biliary tract cancers?

Cancer. 2023 Apr 1;129(7):1129-1130. doi: 10.1002/cncr.34660. Epub 2023 Jan 24.

Oliver Klein^{1

2}, Damien Kee^{1

3}, Adnan Nagrial^{4

5}, Ben Markman^{6

7}, Craig Underhill⁸, Michael Michael³, Andreas Behren^{2

9}, Jodie Palmer^{2

9}, Niall C Tebbutt^{1

10}, Matteo S Carlino^{4

5}, Jonathan Cebon^{1

2

9}

¹ Department of Medical Oncology, Austin Health, Heidelberg, Victoria, Australia.
² Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia.
³ Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
⁴ Blacktown Hospital, Blacktown, New South Wales, Australia.
⁵ University of Sydney, Sydney, New South Wales, Australia.
⁶ Department of Medical Oncology, Alfred Health, Prahran, Victoria, Australia.
⁷ Monash University, Melbourne, Victoria, Australia.
⁸ Albury-Wodonga Regional Cancer Centre, Albury-Wodonga, New South Wales, Australia.
⁹ School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia.
¹⁰ University of Melbourne, Melbourne, Victoria, Australia.

No abstract available

Publication types